Browsing MIDDLE EAST/AFRICA » Cleaning Systems
Insufficient or inadequate cleaning can have various consequences. From a health point of view, an absence of good cleaning can lead to contaminated drugs with a risk for patients, but also for the workers within the pharmaceutical company due to a lack of correct protection. The ecological problems can be summarized in pollution risks. The regulatory issues are linked with warnings from agencies up to possible authorization withdrawn. Economic problems start with a diminution of production and stock shortage which imply increased internal costs and financial loss. In addition, image problems for a company exist when patients must return medications to the pharmacy as in the case of batch recall.
Contamination is a process with three main factors: the source of contamination (i.e. previous API or excipients, cleaning agents), the vector (for example, unclean apparatus or co-workers), and the receptor (for example, the next batch). Numerous solutions exist to break the links between the factors, and cleaning is one of the most critical. Cleaning should be efficient in all parts of the equipment, but also in rooms and for all the parts or places in which contamination could exist. Some zones which are not easy to clean (O rings, U-bend, etc.) are often called critical points that are defined as “zones or spots in systems on which an absence of control will bring an unacceptable risk for security.
A perfect Pharmaceutical buyers/suppliers directory
04-02-2016New Material Trade Center
250100
ASIA-PACIFIC
supplier of pharmaceutical raw materials and
(144 views since 06-18-2020 01:57AM)
45 Eisenhower Drive, Suite 350
07652
NORTH AMERICA
A design-build company specializing in the modular
(244 views since 11-29-2019 03:36AM)
Tennoz central tower 4F, 2-2-24, Higashi-Shinagawa, Shigawa-ku, Tokyo, JAPAN
1400002
ASIA-PACIFIC
Contract Manufacturing for Commercial High Potent
(416 views since 04-07-2016 10:02PM)
Disease/Medical Use: HIV infection
Disease/Medical Use: Asthma; chronic obstructive
Disease/Medical Use: Diabetes mellitus type 1 and
Disease/Medical Use: Psoriasis; psoriatic
Disease/Medical Use: Diabetes mellitus type 1 and
ScyTek laboratories inc Biotech manufactures diagnostic reagents, Special Stains, Antibodies, Hematology, Immunohistochemistry, buffers, Microbiology
High purity of pharmaceutical intermediates
Name: 2-Methyl-4-(Trifluoromethyl) thiazole-5-carboxylic acidCas No: 117724-63-7Appearance: White to off-white powderPurity: 96.3%Molecular formula